Polydatin
A stilbene glycoside.
C1=CC(=CC=C1/C=C/C2=CC(=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O
Supporting references
| Link | Tested on | Impact factor | Notes | Publication date |
|---|---|---|---|---|
|
Discovering drugs to treat coronavirus disease 2019 (COVID-19).
|
in silico | Feb/22/2020 | ||
|
Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13)
nsp13 Small molecule In silico |
in silico | 5.16 | Predicted to inhibit the SARS-CoV-2 nsp13 helicase (both wild type and with C17747T and A17858G mutations). |
Sep/24/2020 |
|
Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study
3CLpro Small molecule Animal model Moderate severity Mild severity Mixed substance Cohort study In silico |
in silico; patients; BALB/c mice (HCoV-229E virus infection only) | 4.27 | Predicted to bind the SARS-CoV-2 3C-like protease. |
Oct/22/2020 |
